JAZZ
Jazz Pharmaceuticals plc
Stock
$235.67+2.66 (+1.14%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $291M
- YoY, 2025
- +17.4%
- 5-year CAGR
- +19.2%
- 10-year CAGR
- +12.3%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $291M | +17.4% |
| 2024 | $248M | +9.3% |
| 2023 | $227M | +2.2% |
| 2022 | $222M | +17.5% |
| 2021 | $189M | +56.2% |
| 2020 | $121M | +9.4% |
| 2019 | $111M | +7.9% |
| 2018 | $102M | −4.2% |
| 2017 | $107M | +8.2% |
| 2016 | $99M | +7.9% |
| 2015 | $92M | +31.5% |
| 2014 | $70M | +56.3% |
| 2013 | $45M | +93.6% |
| 2012 | $23M | +11.1% |
| 2011 | $21M | +151.9% |
| 2010 | $8.2M | +38.0% |
| 2009 | $6.0M | — |